查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1224482

慢性阻塞性肺病（COPD）的全球市场和COVID-19影响的分析:各COPD类型，不同治疗，各终端用户，各国，各地区 - 产业分析，市场规模，市场占有率，预测(2023年～2030年)

Chronic Obstructive Pulmonary Disease Market with COVID-19 Impact Analysis, By COPD Type, By Treatment, By End User, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2023-2030
出版日期: | 出版商: AnalystView Market Insights | 英文 311 Pages | 商品交期: 2-3个工作天内

价格

全球慢性阻塞性肺病（COPD）的市场规模在2022年估算为196亿790万美金，在2023年～2030年间预计将以年复合成长率5.8％的速度成长。

本报告提供全球慢性阻塞性肺病（COPD）市场相关调查分析，提供市场趋势，市场区隔分析，地区分析，企业简介等资讯。

目录

第1章 慢性阻塞性肺病（COPD）市场概要

第2章 摘要整理

  • 市场明细
    • 慢性阻塞性肺病（COPD）市场明细:各COPD类型
    • 慢性阻塞性肺病（COPD）市场明细:各治疗类型
    • 慢性阻塞性肺病（COPD）市场明细:各终端用户
    • 慢性阻塞性肺病（COPD）市场明细:各国
    • 慢性阻塞性肺病（COPD）市场明细
  • 竞争考察

第3章 慢性阻塞性肺病（COPD）的主要市场趋势

  • 慢性阻塞性肺病（COPD）市场促进因素
    • 推动市场要素的影响的分析
  • 慢性阻塞性肺病（COPD）市场阻碍因素
    • 阻碍市场要素的影响的分析
  • 慢性阻塞性肺病（COPD）市场机会
  • 慢性阻塞性肺病（COPD）市场未来趋势

第4章 慢性阻塞性肺病（COPD）产业的调查

  • PEST分析
  • 波特的五力分析
  • 成长预测的製图
  • 法律规范的分析

第5章 慢性阻塞性肺病（COPD）市场:COVID-19影响的分析

  • COVID-19前的影响的分析
  • COVID-19后的影响的分析

第6章 慢性阻塞性肺病（COPD）市场形势

  • 慢性阻塞性肺病（COPD）的市场占有率分析(2022年)
  • 明细资料:各主要製造商
    • 现有企业的分析
    • 新兴企业的分析

第7章 慢性阻塞性肺病（COPD）市场 - 各COPD类型

  • 概要

第8章 慢性阻塞性肺病（COPD）市场 - 各治疗类型

  • 概要

第9章 慢性阻塞性肺病（COPD）市场 - 各终端用户

  • 概要

第10章 慢性阻塞性肺病（COPD）市场 - 各地区

  • 简介
  • 北美
  • 欧洲
  • 亚太地区
  • 南美
  • 中东·非洲

第11章 主要供应商的分析 - 慢性阻塞性肺病（COPD）产业

  • 竞争仪表板
  • 企业简介
    • Biomarck Pharmaceuticals
    • AstraZeneca
    • Amgen
    • Afimmune
    • Boehringer Ingelheim Pharmaceuticals
    • Chiesi Farmaceutici S.p.A.
    • Genentech
    • Circassia Pharmaceuticals Inc.
    • GlaxoSmithKline
    • Inmunotek
    • Mereo BioPharma
    • Innoviva
    • Novartis Pharmaceuticals

第12章 分析师的见解

第13章 附录

Product Code: ANV1121

REPORT HIGHLIGHT

Chronic Obstructive Pulmonary Disease Market size was valued at USD 19,607.9 Million in 2022, expanding at a CAGR of 5.8% from 2023 to 2030.

A chronic inflammatory lung disease called chronic obstructive pulmonary disease (COPD) restricts airflow from the lungs. Breathing problems, coughing up mucus, wheezing, and other symptoms are all signs of COPD. In most cases, exposure to noxious gases and particulate matter over an extended period-often from cigarette smoke-is what causes it. If COPD is severe, people may develop heart disease, lung cancer, as well as several other diseases. Emphysema and chronic bronchitis are two common medical disorders that affect COPD sufferers.

Chronic Obstructive Pulmonary Disease Market- Market Dynamics

A significant global health issue, chronic obstructive pulmonary disease (COPD) affects a lot of individuals. The demand for COPD care is growing as the disease burden grows as well. COPD might be brought on by tobacco use. The adult smoking addiction has become more prevalent all over the world. Workplace pollution and indoor air pollution are additional risk factors. The World Health Organization (WHO) claims that exposure to cigarette smoke is the main cause of COPD. The organization estimates that 3.23 million deaths will be caused by chronic obstructive pulmonary disease (COPD), making it the third greatest cause of mortality worldwide. In low- and middle-income nations, COPD fatalities in people under 70 years of age account for about 90% of all mortality (LMIC). Thus, the growing prevalence of COPD across the globe is expected to drive market growth over the forecast period. However, it is projected that the market expansion would be constrained by the high cost of COPD therapy and the lack of awareness about COPD. Additionally, the expiration of patents is a significant barrier for the worldwide industry. Furthermore, throughout the anticipated term, the government's approval for generic medications and biosimilars is anticipated to create enormous market prospects.

Chronic Obstructive Pulmonary Disease Market- Segmentation Analysis:

Based on the COPD type, the global market is segmented into chronic bronchitis and emphysema. The chronic bronchitis segment is expected to hold the largest market share over the forecast period. The growth in the segment is attributed to increased cigarette use, and increased industrialization, which causes air pollution and the release of toxic gases into the environment, which are all contributing to an increase in the incidence and prevalence of chronic bronchitis across the world. For instance, according to the CDC, in 2020, 12.5% of adults in the United States (an estimated 30.8 million individuals) smoked cigarettes: 14.1% of males and 11% of women. Thus, these facts support the segmental growth over the forecast period.

The market is divided into hospitals, clinics, homecare settings, and others based on the end user. The hospital segment is predicted to expand at the fastest CAGR during the forecast period due to an increase in the number of patients suffering from different chronic respiratory illnesses as well as lifestyle disorders, as well as increased awareness about these diseases. Furthermore, the availability of different diagnostics and treatment facilities increased buying power, and the presence of highly skilled healthcare professionals are propelling the worldwide chronic obstructive pulmonary disease market in the hospital segment.

Chronic Obstructive Pulmonary Disease Market- Geographical Insights

In terms of revenue, North America leads the worldwide market for chronic obstructive pulmonary disease in 2022 and is anticipated to continue to do so for the duration of the forecast period. The increased investment in R&D efforts for the creation of novel medications for the treatment of different chronic respiratory diseases as well as lifestyle conditions is primarily responsible for the revenue rise in the North American market. Besides, the market in the Asia Pacific is anticipated to grow at a significant rate during the forecast period due to factors such as increased focus given to the building projects of healthcare infrastructure, an increase in the prevalence of various chronic respiratory diseases as well as lifestyle diseases, an increase in industrialization, changes in lifestyle, and an increase in the number of patients suffering from COPD in developing countries like China and India.

Chronic Obstructive Pulmonary Disease Market- Recent Development:

In July 2020, Enerzair Breezhaler (indacaterol acetate, glycopyrronium bromide, and mometasone furoate [IND/GLY/MF]) was approved by the European Commission (EC) as a maintenance treatment for adult patients with asthma whose symptoms were insufficiently controlled by a maintenance regimen involving a long-acting beta2-agonist (LABA) and a high dose of an inhaled corticosteroid (ICS).

Key features of the study:

This proposed research study on the Chronic Obstructive Pulmonary Disease market provides market size (US$ million), compound annual growth rate (CAGR %) and forecast estimation (2023-2030), considering 2022 as the base year

The research report elucidates potential growth opportunities across different segments/countries and explains an attractive investment proposition matrix for ` the Chronic Obstructive Pulmonary Disease market

The overall report identifies new investment opportunities, challenges faced by established players, and growth factors to sustain the Chronic Obstructive Pulmonary Disease market

The impact of COVID-19 on the Chronic Obstructive Pulmonary Disease market size, forecast, CAGR, and market dynamics are discussed in detail under the research scope. Detailed insight into the Chronic Obstructive Pulmonary Disease market post-COVID will also be covered.

To give the users of this report a comprehensive view of the Chronic Obstructive Pulmonary Disease market, we have also included a competitive landscape and key innovator analysis for the Chronic Obstructive Pulmonary Disease market.

The study encompasses a growth prospect mapping analysis, wherein all the industry segments are benchmarked based on their market size, growth rate and attractiveness.

The report offers detailed company profiling featuring major market participants which will help users to understand the financial information and strategic initiatives of players operating in the Chronic Obstructive Pulmonary Disease market.

In addition, the report also unveils the important acquisitions & mergers, collaborations & joint ventures, new launches, research & development, and regional expansion of major participants involved in the market on global as well as regional levels.

The global Chronic Obstructive Pulmonary Disease market report primarily caters to various stakeholders in this industry including suppliers, investors, new entrants, distributors, and financial analysts

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL CHRONIC OBSTRUCTIVE PULMONARY DISEASE MARKET KEY PLAYERS

Biomarck Pharmaceuticals

AstraZeneca

Amgen

Afimmune

Boehringer Ingelheim Pharmaceuticals

Chiesi Farmaceutici S.p.A.

Genentech

Circassia Pharmaceuticals Inc.

GlaxoSmithKline

Inmunotek

Mereo BioPharma

Innoviva

Novartis Pharmaceuticals

GLOBAL CHRONIC OBSTRUCTIVE PULMONARY DISEASE MARKET, BY COPD TYPE

Chronic Bronchitis

Emphysema

GLOBAL CHRONIC OBSTRUCTIVE PULMONARY DISEASE MARKET, BY TREATMENT

Drugs

Oxygen Therapy

Surgery

Others

GLOBAL CHRONIC OBSTRUCTIVE PULMONARY DISEASE MARKET, BY END USER

Hospitals

Clinics

Homecare Settings

Others

GLOBAL CHRONIC OBSTRUCTIVE PULMONARY DISEASE MARKET, BY REGION

North America

The U.S.

Canada

Europe

Germany

France

Italy

Spain

United Kingdom

Russia

Netherlands

Sweden

Poland

Rest of Europe

Asia Pacific

India

China

South Korea

Japan

Australia

Thailand

Indonesia

Philippines

Rest of APAC

Latin America

Brazil

Mexico

Argentina

Colombia

Rest of LATAM

The Middle East and Africa

Saudi Arabia

United Arab Emirates

Israel

Turkey

Algeria

Egypt

Rest of MEA

TABLE OF CONTENT

1. Chronic Obstructive Pulmonary Disease Market Overview

  • 1.1. Study Scope

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Chronic Obstructive Pulmonary Disease Market Snippet by COPD Type
    • 2.1.2. Chronic Obstructive Pulmonary Disease Market Snippet by Treatment Type
    • 2.1.3. Chronic Obstructive Pulmonary Disease Market Snippet by End User
    • 2.1.4. Chronic Obstructive Pulmonary Disease Market Snippet by Country
    • 2.1.5. Chronic Obstructive Pulmonary Disease Market Snippet by Region
  • 2.2. Competitive Insights

3. Chronic Obstructive Pulmonary Disease Key Market Trends

  • 3.1. Chronic Obstructive Pulmonary Disease Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Chronic Obstructive Pulmonary Disease Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Chronic Obstructive Pulmonary Disease Market Opportunities
  • 3.4. Chronic Obstructive Pulmonary Disease Market Future Trends

4. Chronic Obstructive Pulmonary Disease Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Chronic Obstructive Pulmonary Disease Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. Chronic Obstructive Pulmonary Disease Market Landscape

  • 6.1. Chronic Obstructive Pulmonary Disease Market Share Analysis, 2022
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Chronic Obstructive Pulmonary Disease Market - By COPD Type

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By COPD Type, 2022 & 2030 (%)
    • 7.1.2. Chronic Bronchitis
    • 7.1.3. Emphysema

8. Chronic Obstructive Pulmonary Disease Market - By Treatment Type

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Treatment Type, 2022 & 2030 (%)
    • 8.1.2. Drugs
    • 8.1.3. Oxygen Therapy
    • 8.1.4. Surgery
    • 8.1.5. Others

9. Chronic Obstructive Pulmonary Disease Market - By End User

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By End User, 2022 & 2030 (%)
    • 9.1.2. Hospitals
    • 9.1.3. Clinics
    • 9.1.4. Homecare Settings
    • 9.1.5. Others

10. Chronic Obstructive Pulmonary Disease Market- By Geography

  • 10.1. Introduction
    • 10.1.1. Segment Share Analysis, By Geography, 2022 & 2030 (%)
  • 10.2. North America
    • 10.2.1. Overview
    • 10.2.2. Chronic Obstructive Pulmonary Disease Key Manufacturers in North America
    • 10.2.3. North America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.2.4. North America Market Size and Forecast, By COPD Type, 2018 - 2030 (US$ Million)
    • 10.2.5. North America Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
    • 10.2.6. North America Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.2.7. U.S.
      • 10.2.7.1. Overview
      • 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.2.7.3. U.S. Market Size and Forecast, By COPD Type, 2018 - 2030 (US$ Million)
      • 10.2.7.4. U.S. Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
      • 10.2.7.5. U.S. Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.2.8. Canada
      • 10.2.8.1. Overview
      • 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.2.8.3. Canada Market Size and Forecast, By COPD Type, 2018 - 2030 (US$ Million)
      • 10.2.8.4. Canada Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
      • 10.2.8.5. Canada Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
  • 10.3. Europe
    • 10.3.1. Overview
    • 10.3.2. Chronic Obstructive Pulmonary Disease Key Manufacturers in Europe
    • 10.3.3. Europe Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.3.4. Europe Market Size and Forecast, By COPD Type, 2018 - 2030 (US$ Million)
    • 10.3.5. Europe Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
    • 10.3.6. Europe Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.3.7. Germany
      • 10.3.7.1. Overview
      • 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.7.3. Germany Market Size and Forecast, By COPD Type, 2018 - 2030 (US$ Million)
      • 10.3.7.4. Germany Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
      • 10.3.7.5. Germany Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.3.8. Italy
      • 10.3.8.1. Overview
      • 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.8.3. Italy Market Size and Forecast, By COPD Type, 2018 - 2030 (US$ Million)
      • 10.3.8.4. Italy Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
      • 10.3.8.5. Italy Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.3.9. United Kingdom
      • 10.3.9.1. Overview
      • 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.9.3. United Kingdom Market Size and Forecast, By COPD Type, 2018 - 2030 (US$ Million)
      • 10.3.9.4. United Kingdom Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
      • 10.3.9.5. United Kingdom Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.3.10. France
      • 10.3.10.1. Overview
      • 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.10.3. France Market Size and Forecast, By COPD Type, 2018 - 2030 (US$ Million)
      • 10.3.10.4. France Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
      • 10.3.10.5. France Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.3.11. Russia
      • 10.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.11.2. Russia Market Size and Forecast, By COPD Type, 2018 - 2030 (US$ Million)
      • 10.3.11.3. Russia Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
      • 10.3.11.4. Russia Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.3.12. Netherlands
      • 10.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.12.2. Netherlands Market Size and Forecast, By COPD Type, 2018 - 2030 (US$ Million)
      • 10.3.12.3. Netherlands Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
      • 10.3.12.4. Netherlands Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.3.13. Sweden
      • 10.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.13.2. Sweden Market Size and Forecast, By COPD Type, 2018 - 2030 (US$ Million)
      • 10.3.13.3. Sweden Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
      • 10.3.13.4. Sweden Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.3.14. Poland
      • 10.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.14.2. Poland Market Size and Forecast, By COPD Type, 2018 - 2030 (US$ Million)
      • 10.3.14.3. Poland Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
      • 10.3.14.4. Poland Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.3.15. Rest of Europe
      • 10.3.15.1. Overview
      • 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.15.3. Rest of the Europe Market Size and Forecast, By COPD Type, 2018 - 2030 (US$ Million)
      • 10.3.15.4. Rest of the Europe Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
      • 10.3.15.5. Rest of the Europe Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
  • 10.4. Asia Pacific (APAC)
    • 10.4.1. Overview
    • 10.4.2. Chronic Obstructive Pulmonary Disease Key Manufacturers in Asia Pacific
    • 10.4.3. Asia Pacific Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.4.4. Asia Pacific Market Size and Forecast, By COPD Type, 2018 - 2030 (US$ Million)
    • 10.4.5. Asia Pacific Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
    • 10.4.6. Asia Pacific Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.4.7. India
      • 10.4.7.1. Overview
      • 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.7.3. India Market Size and Forecast, By COPD Type, 2018 - 2030 (US$ Million)
      • 10.4.7.4. India Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
      • 10.4.7.5. India Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.4.8. China
      • 10.4.8.1. Overview
      • 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.8.3. China Market Size and Forecast, By COPD Type, 2018 - 2030 (US$ Million)
      • 10.4.8.4. China Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
      • 10.4.8.5. China Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.4.9. Japan
      • 10.4.9.1. Overview
      • 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.9.3. Japan Market Size and Forecast, By COPD Type, 2018 - 2030 (US$ Million)
      • 10.4.9.4. Japan Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
      • 10.4.9.5. Japan Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.4.10. South Korea
      • 10.4.10.1. Overview
      • 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.10.3. South Korea Market Size and Forecast, By COPD Type, 2018 - 2030 (US$ Million)
      • 10.4.10.4. South Korea Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
      • 10.4.10.5. South Korea Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.4.11. Australia
      • 10.4.11.1. Overview
      • 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.11.3. Australia Market Size and Forecast, By COPD Type, 2018 - 2030 (US$ Million)
      • 10.4.11.4. Australia Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
      • 10.4.11.5. Australia Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.4.12. Thailand
      • 10.4.12.1. Overview
      • 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.12.3. Thailand Market Size and Forecast, By COPD Type, 2018 - 2030 (US$ Million)
      • 10.4.12.4. Thailand Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
      • 10.4.12.5. Thailand Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.4.13. Indonesia
      • 10.4.13.1. Overview
      • 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.13.3. Indonesia Market Size and Forecast, By COPD Type, 2018 - 2030 (US$ Million)
      • 10.4.13.4. Indonesia Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
      • 10.4.13.5. Indonesia Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.4.14. Philippines
      • 10.4.14.1. Overview
      • 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.14.3. Philippines Market Size and Forecast, By COPD Type, 2018 - 2030 (US$ Million)
      • 10.4.14.4. Philippines Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
      • 10.4.14.5. Philippines Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.4.15. Rest of APAC
      • 10.4.15.1. Overview
      • 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.15.3. Rest of APAC Market Size and Forecast, By COPD Type, 2018 - 2030 (US$ Million)
      • 10.4.15.4. Rest of APAC Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
      • 10.4.15.5. Rest of APAC Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
  • 10.5. Latin America
    • 10.5.1. Overview
    • 10.5.2. Chronic Obstructive Pulmonary Disease Key Manufacturers in Latin America
    • 10.5.3. Latin America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.5.4. Latin America Market Size and Forecast, By COPD Type, 2018 - 2030 (US$ Million)
    • 10.5.5. Latin America Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
    • 10.5.6. Latin America Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.5.7. Brazil
      • 10.5.7.1. Overview
      • 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.7.3. Brazil Market Size and Forecast, By COPD Type, 2018 - 2030 (US$ Million)
      • 10.5.7.4. Brazil Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
      • 10.5.7.5. Brazil Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.5.8. Mexico
      • 10.5.8.1. Overview
      • 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.8.3. Mexico Market Size and Forecast, By COPD Type, 2018 - 2030 (US$ Million)
      • 10.5.8.4. Mexico Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
      • 10.5.8.5. Mexico Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.5.9. Argentina
      • 10.5.9.1. Overview
      • 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.9.3. Argentina Market Size and Forecast, By COPD Type, 2018 - 2030 (US$ Million)
      • 10.5.9.4. Argentina Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
      • 10.5.9.5. Argentina Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.5.10. Colombia
      • 10.5.10.1. Overview
      • 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.10.3. Colombia Market Size and Forecast, By COPD Type, 2018 - 2030 (US$ Million)
      • 10.5.10.4. Colombia Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
      • 10.5.10.5. Colombia Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.5.11. Rest of LATAM
      • 10.5.11.1. Overview
      • 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.11.3. Rest of LATAM Market Size and Forecast, By COPD Type, 2018 - 2030 (US$ Million)
      • 10.5.11.4. Rest of LATAM Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
      • 10.5.11.5. Rest of LATAM Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
  • 10.6. Middle East and Africa
    • 10.6.1. Overview
    • 10.6.2. Chronic Obstructive Pulmonary Disease Key Manufacturers in Middle East and Africa
    • 10.6.3. Middle East and Africa Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.6.4. Middle East and Africa Market Size and Forecast, By COPD Type, 2018 - 2030 (US$ Million)
    • 10.6.5. Middle East and Africa Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
    • 10.6.6. Middle East and Africa Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.6.7. Saudi Arabia
      • 10.6.7.1. Overview
      • 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.7.3. Saudi Arabia Market Size and Forecast, By COPD Type, 2018 - 2030 (US$ Million)
      • 10.6.7.4. Saudi Arabia Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
      • 10.6.7.5. Saudi Arabia Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.6.8. United Arab Emirates
      • 10.6.8.1. Overview
      • 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.8.3. United Arab Emirates Market Size and Forecast, By COPD Type, 2018 - 2030 (US$ Million)
      • 10.6.8.4. United Arab Emirates Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
      • 10.6.8.5. United Arab Emirates Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.6.9. Israel
      • 10.6.9.1. Overview
      • 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.9.3. Israel Market Size and Forecast, By COPD Type, 2018 - 2030 (US$ Million)
      • 10.6.9.4. Israel Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
      • 10.6.9.5. Israel Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.6.10. Turkey
      • 10.6.10.1. Overview
      • 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.10.3. Turkey Market Size and Forecast, By COPD Type, 2018 - 2030 (US$ Million)
      • 10.6.10.4. Turkey Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
      • 10.6.10.5. Turkey Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.6.11. Algeria
      • 10.6.11.1. Overview
      • 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.11.3. Algeria Market Size and Forecast, By COPD Type, 2018 - 2030 (US$ Million)
      • 10.6.11.4. Algeria Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
      • 10.6.11.5. Algeria Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.6.12. Egypt
      • 10.6.12.1. Overview
      • 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.12.3. Egypt Market Size and Forecast, By COPD Type, 2018 - 2030 (US$ Million)
      • 10.6.12.4. Egypt Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
      • 10.6.12.5. Egypt Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.6.13. Rest of MEA
      • 10.6.13.1. Overview
      • 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.13.3. Rest of MEA Market Size and Forecast, By COPD Type, 2018 - 2030 (US$ Million)
      • 10.6.13.4. Rest of MEA Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
      • 10.6.13.5. Rest of MEA Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)

11. Key Vendor Analysis- Chronic Obstructive Pulmonary Disease Industry

  • 11.1. Competitive Dashboard
  • 11.2. Company Profiles
    • 11.2.1. Biomarck Pharmaceuticals
    • 11.2.2. AstraZeneca
    • 11.2.3. Amgen
    • 11.2.4. Afimmune
    • 11.2.5. Boehringer Ingelheim Pharmaceuticals
    • 11.2.6. Chiesi Farmaceutici S.p.A.
    • 11.2.7. Genentech
    • 11.2.8. Circassia Pharmaceuticals Inc.
    • 11.2.9. GlaxoSmithKline
    • 11.2.10. Inmunotek
    • 11.2.11. Mereo BioPharma
    • 11.2.12. Innoviva
    • 11.2.13. Novartis Pharmaceuticals

12. 360 Degree Analyst View

13. Appendix

  • 13.1. Research Methodology
  • 13.2. References
  • 13.3. Abbreviations
  • 13.4. Disclaimer
  • 13.5. Contact Us

List of Tables

  • TABLE List of data sources
  • TABLE Market drivers; Impact Analysis
  • TABLE Market restraints; Impact Analysis
  • TABLE Chronic Obstructive Pulmonary Disease Market:COPD Type Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by COPD Type
  • TABLE Global Chronic Obstructive Pulmonary Disease Market, by COPD Type 2018-2030 (USD Million)
  • TABLE Chronic Obstructive Pulmonary Disease Market: Treatment Type Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Treatment Type
  • TABLE Global Chronic Obstructive Pulmonary Disease Market, by Treatment Type 2018-2030 (USD Million)
  • TABLE Chronic Obstructive Pulmonary Disease Market: Regional snapshot (2022)
  • TABLE Chronic Obstructive Pulmonary Disease Market: End User Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by End User
  • TABLE Global Chronic Obstructive Pulmonary Disease Market, by End User 2018-2030 (USD Million)
  • TABLE Segment Dashboard; Definition and Scope, by Region
  • TABLE Global Chronic Obstructive Pulmonary Disease Market, by Region 2018-2030 (USD Million)
  • TABLE North America Chronic Obstructive Pulmonary Disease Market, by Country, 2018-2030 (USD Million)
  • TABLE North America Chronic Obstructive Pulmonary Disease Market, by COPD Type, 2018-2030 (USD Million)
  • TABLE North America Chronic Obstructive Pulmonary Disease Market, by Treatment Type, 2018-2030 (USD Million)
  • TABLE North America Chronic Obstructive Pulmonary Disease Market, by End User, 2018-2030 (USD Million)
  • TABLE Europe Chronic Obstructive Pulmonary Disease Market, by Country, 2018-2030 (USD Million)
  • TABLE Europe Chronic Obstructive Pulmonary Disease Market, by COPD Type, 2018-2030 (USD Million)
  • TABLE Europe Chronic Obstructive Pulmonary Disease Market, by Treatment Type, 2018-2030 (USD Million)
  • TABLE Europe Chronic Obstructive Pulmonary Disease Market, by End User, 2018-2030 (USD Million)
  • TABLE Asia Pacific Chronic Obstructive Pulmonary Disease Market, by Country, 2018-2030 (USD Million)
  • TABLE Asia Pacific Chronic Obstructive Pulmonary Disease Market, by COPD Type, 2018-2030 (USD Million)
  • TABLE Asia Pacific Chronic Obstructive Pulmonary Disease Market, by Treatment Type, 2018-2030 (USD Million)
  • TABLE Asia Pacific Chronic Obstructive Pulmonary Disease Market, by End User, 2018-2030 (USD Million)
  • TABLE Latin America Chronic Obstructive Pulmonary Disease Market, by Country, 2018-2030 (USD Million)
  • TABLE Latin America Chronic Obstructive Pulmonary Disease Market, by COPD Type, 2018-2030 (USD Million)
  • TABLE Latin America Chronic Obstructive Pulmonary Disease Market, by Treatment Type, 2018-2030 (USD Million)
  • TABLE Latin America Chronic Obstructive Pulmonary Disease Market, by End User, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Chronic Obstructive Pulmonary Disease Market, by Country, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Chronic Obstructive Pulmonary Disease Market, by COPD Type, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Chronic Obstructive Pulmonary Disease Market, by Treatment Type, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Chronic Obstructive Pulmonary Disease Market, by End User, 2018-2030 (USD Million)